Laboratory for Clinical Neuroscience, Center for Biomedical Technology, Universidad Politécnica de Madrid, IdISSC, Madrid, Spain.
Alzheimer's Disease Research Unit, CIEN Foundation, Queen Sofia Foundation Alzheimer Center, Madrid, Spain.
Alzheimers Dement. 2023 Nov;19(11):5307-5315. doi: 10.1002/alz.13352. Epub 2023 Jun 27.
Hippocampal sclerosis of aging (HS) is an important component of combined dementia neuropathology. However, the temporal evolution of its histologically-defined features is unknown. We investigated pre-mortem longitudinal hippocampal atrophy associated with HS, as well as with other dementia-associated pathologies.
We analyzed hippocampal volumes from magnetic resonance imaging (MRI) segmentations in 64 dementia patients with longitudinal MRI follow-up and post-mortem neuropathological evaluation, including HS assessment in the hippocampal head and body.
Significant HS-associated hippocampal volume changes were observed throughout the evaluated timespan, up to 11.75 years before death. These changes were independent of age and Alzheimer's disease (AD) neuropathology and were driven specifically by CA1 and subiculum atrophy. AD pathology, but not HS, was associated significantly with the rate of hippocampal atrophy.
HS-associated volume changes are detectable on MRI earlier than 10 years before death. Based on these findings, volumetric cutoffs could be derived for in vivo differentiation between HS and AD.
Hippocampal atrophy was found in HS+ patients earlier than 10 years before death. These early pre-mortem changes were driven by reduced CA1 and subiculum volumes. Rates of hippocampus and subfield volume decline were independent of HS. In contrast, steeper atrophy rates were associated with AD pathology burden. Differentiation between AD and HS could be facilitated based on these MRI findings.
衰老性海马硬化(HS)是合并痴呆神经病理学的一个重要组成部分。然而,其组织学定义特征的时间演变尚不清楚。我们研究了与 HS 以及其他与痴呆相关的病理学相关的生前纵向海马萎缩。
我们分析了 64 名痴呆症患者的磁共振成像(MRI)分割海马体积,这些患者具有纵向 MRI 随访和死后神经病理学评估,包括海马头部和体部的 HS 评估。
在评估的整个时间段内,都观察到了与 HS 相关的显著海马体积变化,直到死亡前 11.75 年。这些变化与年龄和阿尔茨海默病(AD)神经病理学无关,而是由 CA1 和下托萎缩特异性驱动。AD 病理学而不是 HS 与海马萎缩的速度显著相关。
在死亡前 10 年之前,通过 MRI 就可以检测到与 HS 相关的体积变化。基于这些发现,可以得出用于区分 HS 和 AD 的活体体积截断值。
在 HS+患者中,海马萎缩的出现早于死亡前 10 年。这些早期的生前变化是由 CA1 和下托体积减少驱动的。海马体和子区域体积下降的速度与 HS 无关。相比之下,AD 病理学负担与更快的萎缩速度相关。基于这些 MRI 发现,可以促进 AD 和 HS 之间的区分。